SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-004165
Filing Date
2019-05-07
Accepted
2019-05-07 08:22:35
Documents
64
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q vygr-20190331x10q.htm 10-Q 2365761
2 EX-10.5 vygr-20190331ex105275c9a.htm EX-10.5 206299
3 EX-31.1 vygr-20190331ex311fe6ffa.htm EX-31.1 15706
4 EX-31.2 vygr-20190331ex3128e0dad.htm EX-31.2 15642
5 EX-32.1 vygr-20190331ex3215de0c3.htm EX-32.1 15360
6 GRAPHIC vygr20190331x10q001.jpg GRAPHIC 112668
  Complete submission text file 0001558370-19-004165.txt   8506868

Data Files

Seq Description Document Type Size
7 EX-101.INS vygr-20190331.xml EX-101.INS 1628889
8 EX-101.SCH vygr-20190331.xsd EX-101.SCH 67726
9 EX-101.CAL vygr-20190331_cal.xml EX-101.CAL 53786
10 EX-101.DEF vygr-20190331_def.xml EX-101.DEF 270650
11 EX-101.LAB vygr-20190331_lab.xml EX-101.LAB 522221
12 EX-101.PRE vygr-20190331_pre.xml EX-101.PRE 415867
Mailing Address 75 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 75 SIDNEY STREET CAMBRIDGE MA 02139 857-259-5340
Voyager Therapeutics, Inc. (Filer) CIK: 0001640266 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37625 | Film No.: 19801361
SIC: 2836 Biological Products, (No Diagnostic Substances)